[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - SurgeryIntervention group: Group receiving mesenchymal stem cells. In this group, patients in 3 times (1, 3 and 6 days) are received 1 million Umbilical core-derived MSCc/BW by intravenous injection ( Through the catheter and the Central vein and from the superior vena cava vein ). Also, in addition to cell therapy,Other common treatments will be given to patients according to the physician's supervision.Mesenchymal Stem cells had an ISCT standard and were given from a healthy donor. Blood samples were given from patients on days 0, 2, and 7, as well as 14 days after the second injection and patients will follow for 20 days (in terms of clinical and immunological parameters).It should be noted that of all patients at the beginning of the study conscious consent form will be received.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - SurgeryControl group: Receiving common therapies (without stem cell). In this group, patients are received other common treatments including antiviral drugs and etc In accordance with the physician's opinion and do not receive stem cells.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 787, "treatment_name": "Mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]